Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Mol Genet Metab. 2012 Jul 16;107(1-2):3–9. doi: 10.1016/j.ymgme.2012.07.005

Table 1.

Core conditions screened in the newborn period categorized by screening methodology and family of disorder.

Tandem Mass Spectrometry
Hematology Others
Acylcarnitines
Organic Acidurias Fatty Acid Oxidation Amino Acids
Isovaleric acidemia
Glutaric acidemia type I
3-Hydroxy 3 –methyl glutaric aciduria
Multiple carboxylase deficiency
Methylmalonic acidemia
3-Methylcrotonyl-CoA carboxylase deficiency
Propionic acidemia
β-Ketothiolase
Medium-chain acyl- CoA dehydrogenase deficiency
Very long-chain acyl- CoA dehydrogenase deficiency
Long-chain L-3- hydroxyacyl-CoA dehydrogenase
Trifunctional protein deficiency
Carnitine uptake defect
Phenylketonuria
Maple syrup (urine) disease
Homocystinuria
Citrullinemia
Argininosuccinic aciduria
Tyrosinemia type I
Sickle cell anemia
Hb S/β thalassemia
Hb S/C disease
Congenital hypothyroid
Biotinidase
Congenital adrenal hyperplasia
Classical galactosemia
Hearing loss
Cystic fibrosis
Severe combined immunodeficiency

Diseases in bold are treated with medical foods and/or single amino acids and amino acid mixtures, vitamins, and other compounds. Terminology consistent with [23].